Skip to Main Content

Paper Details

SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer.
Clin Cancer Res
15
2022
Author NameAffiliation
Jeffrey S RossFoundation Medicine
Jeffrey S RossUpstate Medical University
Emmanuel S AntonarakisUniversity of Minnesota Masonic Cancer Center
Neeraj AgarwalHuntsman Cancer Institute, University of Utah
  • 1 - 4

Datasets

Release 1.2